NOS3 and type 2 diabetes mellitus: Endogenous nitric oxide (eNOS, pg/ml) levels in human cardiac microvascular endothelia cells (from diabetic type 2) were decreased after treatment with 5 or 10 mg/ml of GbG5 (67.4%) or GbG10 (62.9%).